Effects of web platform delivery of a physical activity program for breast cancer survivors: a randomized controlled trial.

IF 3.1 2区医学 Q2 ONCOLOGY

Journal of Cancer Survivorship Pub Date : 2025-05-27 DOI:10.1007/s11764-025-01811-7

Bernardine M Pinto, Madison Kindred, Shira Dunsiger, Sheryl Mitchell, Ashwin Patel, Danielle Ostendorf, Amy G Huebschmann

{"title":"Effects of web platform delivery of a physical activity program for breast cancer survivors: a randomized controlled trial.","authors":"Bernardine M Pinto, Madison Kindred, Shira Dunsiger, Sheryl Mitchell, Ashwin Patel, Danielle Ostendorf, Amy G Huebschmann","doi":"10.1007/s11764-025-01811-7","DOIUrl":null,"url":null,"abstract":"Purpose: We previously demonstrated that a 3-month peer-delivered program (Moving Forward Together, MFT) significantly increased breast cancer survivors' moderate-to-vigorous PA (MVPA). To enhance MFT's scalability and reach, we adapted it to an existing web platform and developed webMFT. Our goal was to test the efficacy of webMFT on survivors' MVPA.Methods: In a randomized controlled trial, we trained ten peer coaches from cancer care organizations to deliver webMFT or MVPA Tracking to 61 breast cancer survivors (mean age = 58.10 years [SD = 8.55], 1.40 years post-diagnosis [SD = 0.50], 80% Stage 0-1 cancer) for 3 months. Both groups received a FitBit® tracker and behavioral supports of weekly synchronization reminders, physical activity (PA) tipsheets, and recommended PA goals. In addition, webMFT participants received weekly coaching calls tailored to their FitBit® data shared through the web platform. All participants wore an Actigraph accelerometer for 7 days at baseline and at post-intervention and completed quality of life (QOL), mood, fatigue and physical functioning questionnaires. We used mixed effects regression models to examine between-group differences on outcomes.Results: Both groups significantly increased their MVPA from baseline to 12 weeks but there were no significant between-group differences in change in MVPA (b = - 22.84, SE = 16.99, p = .18). There were significant between-group effects favoring webMFT in improved QOL at 12 weeks (b = 1.56, SE = 0.77, p = .04).Conclusions: Adapting the efficacious MFT intervention for web delivery did not result in significant improvements in MVPA vs. MVPA Tracking. This raises questions as to whether the efforts undertaken to adapt and deliver the program through the web platform were justified as compared to MVPA Tracking with behavioral supports.Implications for cancer survivors: Promoting PA does not require web delivery of coaching-using physical activity trackers with weekly reminders and resources is also effective.Trial registration: This trial was registered in Clinicaltrials.gov on 6/8/2022 (NCT05409664).","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Survivorship","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11764-025-01811-7","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: We previously demonstrated that a 3-month peer-delivered program (Moving Forward Together, MFT) significantly increased breast cancer survivors' moderate-to-vigorous PA (MVPA). To enhance MFT's scalability and reach, we adapted it to an existing web platform and developed webMFT. Our goal was to test the efficacy of webMFT on survivors' MVPA.

Methods: In a randomized controlled trial, we trained ten peer coaches from cancer care organizations to deliver webMFT or MVPA Tracking to 61 breast cancer survivors (mean age = 58.10 years [SD = 8.55], 1.40 years post-diagnosis [SD = 0.50], 80% Stage 0-1 cancer) for 3 months. Both groups received a FitBit® tracker and behavioral supports of weekly synchronization reminders, physical activity (PA) tipsheets, and recommended PA goals. In addition, webMFT participants received weekly coaching calls tailored to their FitBit® data shared through the web platform. All participants wore an Actigraph accelerometer for 7 days at baseline and at post-intervention and completed quality of life (QOL), mood, fatigue and physical functioning questionnaires. We used mixed effects regression models to examine between-group differences on outcomes.

Results: Both groups significantly increased their MVPA from baseline to 12 weeks but there were no significant between-group differences in change in MVPA (b = - 22.84, SE = 16.99, p = .18). There were significant between-group effects favoring webMFT in improved QOL at 12 weeks (b = 1.56, SE = 0.77, p = .04).

Conclusions: Adapting the efficacious MFT intervention for web delivery did not result in significant improvements in MVPA vs. MVPA Tracking. This raises questions as to whether the efforts undertaken to adapt and deliver the program through the web platform were justified as compared to MVPA Tracking with behavioral supports.

Implications for cancer survivors: Promoting PA does not require web delivery of coaching-using physical activity trackers with weekly reminders and resources is also effective.

Trial registration: This trial was registered in Clinicaltrials.gov on 6/8/2022 (NCT05409664).

查看原文本刊更多论文

网络平台对乳腺癌幸存者体育活动项目的影响：一项随机对照试验。

目的：我们之前证明了一个为期3个月的同行交付项目（Moving Forward Together， MFT）显著增加了乳腺癌幸存者的中度至重度PA （MVPA）。为了增强MFT的可扩展性和覆盖范围，我们将其适应于现有的web平台并开发了webMFT。我们的目的是测试webMFT对幸存者MVPA的疗效。方法：在一项随机对照试验中，我们培训了10名来自癌症护理组织的同行教练，对61名乳腺癌幸存者（平均年龄= 58.10岁[SD = 8.55]，诊断后1.40年[SD = 0.50]， 80%为0-1期癌症）进行为期3个月的webMFT或MVPA跟踪。两组都收到了FitBit®跟踪器和每周同步提醒、体育活动（PA）提示表和推荐的PA目标的行为支持。此外，webMFT参与者每周都会收到针对他们通过网络平台共享的FitBit®数据量身定制的培训电话。所有参与者在基线和干预后都佩戴了7天的Actigraph加速计，并完成了生活质量（QOL）、情绪、疲劳和身体功能问卷。我们使用混合效应回归模型来检验组间结果的差异。结果：从基线到12周，两组患者的MVPA均显著升高，但MVPA变化在两组间无显著差异（b = - 22.84, SE = 16.99, p = 0.18）。webMFT在改善12周生活质量方面有显著的组间效应（b = 1.56, SE = 0.77, p = 0.04）。结论：将有效的MFT干预用于网络传递并没有导致MVPA与MVPA跟踪的显着改善。这就提出了一个问题，即与带有行为支持的MVPA跟踪相比，通过网络平台进行调整和交付程序的努力是否合理。对癌症幸存者的启示：推广PA不需要通过网络提供指导——使用带有每周提醒和资源的体育活动追踪器也很有效。试验注册：该试验于2022年6月8日在Clinicaltrials.gov注册（NCT05409664）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Cancer Survivorship ONCOLOGY-

CiteScore

7.00

自引率

10.80%

发文量

149

审稿时长

>12 weeks

期刊介绍： Cancer survivorship is a worldwide concern. The aim of this multidisciplinary journal is to provide a global forum for new knowledge related to cancer survivorship. The journal publishes peer-reviewed papers relevant to improving the understanding, prevention, and management of the multiple areas related to cancer survivorship that can affect quality of care, access to care, longevity, and quality of life. It is a forum for research on humans (both laboratory and clinical), clinical studies, systematic and meta-analytic literature reviews, policy studies, and in rare situations case studies as long as they provide a new observation that should be followed up on to improve outcomes related to cancer survivors. Published articles represent a broad range of fields including oncology, primary care, physical medicine and rehabilitation, many other medical and nursing specialties, nursing, health services research, physical and occupational therapy, public health, behavioral medicine, psychology, social work, evidence-based policy, health economics, biobehavioral mechanisms, and qualitative analyses. The journal focuses exclusively on adult cancer survivors, young adult cancer survivors, and childhood cancer survivors who are young adults. Submissions must target those diagnosed with and treated for cancer.